Morgan Stanley lowers Ovintiv price target to $65
Morgan Stanley analyst Devin McDermott maintains an Equal-Weight rating on Ovintiv and lowers the price target to $65 from $68, indicating a revised expectation for the stock.

*this image is generated using AI for illustrative purposes only.
Morgan Stanley analyst Devin McDermott has maintained an Equal-Weight rating on Ovintiv while lowering the price target to $65 from $68. The revised target suggests a tempered outlook for the company's stock performance.
The rating decision indicates that the stock is expected to perform in line with the broader market. Ovintiv is listed on the NYSE under the ticker symbol OVV.
| Metric | Value |
|---|---|
| Rating | Equal-Weight |
| Previous Price Target | $68 |
| New Price Target | $65 |
What factors contributed to the decision to lower Ovintiv's price target despite maintaining an Equal-Weight rating?
How might Ovintiv's performance compare to its peers in the energy sector given the revised outlook?
What are the potential risks or opportunities that could influence Ovintiv's stock performance in the coming quarters?























